BSE Live
Sep 23, 16:01Prev. Close
738.20
Open Price
737.05
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Sep 23, 15:59Prev. Close
747.00
Open Price
745.90
Bid Price (Qty.)
738.70 (87)
Offer Price (Qty.)
0.00 (0)
Key Financial Ratios of Supriya Lifescience (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | |
Per Share Ratios | |||||
Basic EPS (Rs.) | 23.35 | 14.80 | 11.16 | 18.86 | |
Diluted EPS (Rs.) | 23.35 | 14.80 | 11.16 | 18.86 | |
Cash EPS (Rs.) | 25.89 | 16.76 | 12.63 | 20.12 | |
Book Value [ExclRevalReserve]/Share (Rs.) | 123.84 | 101.31 | 86.91 | 76.50 | |
Book Value [InclRevalReserve]/Share (Rs.) | 123.84 | 101.31 | 86.91 | 76.50 | |
Dividend / Share(Rs.) | 1.00 | 0.80 | 0.60 | 0.60 | |
Revenue from Operations/Share (Rs.) | 86.54 | 70.87 | 57.27 | 65.86 | |
PBDIT/Share (Rs.) | 33.62 | 22.81 | 17.19 | 27.53 | |
PBIT/Share (Rs.) | 31.08 | 20.85 | 15.73 | 26.27 | |
PBT/Share (Rs.) | 30.87 | 20.59 | 15.34 | 25.75 | |
Net Profit/Share (Rs.) | 23.35 | 14.80 | 11.16 | 18.86 | |
Profitability Ratios | |||||
PBDIT Margin (%) | 38.85 | 32.19 | 30.02 | 41.80 | |
PBIT Margin (%) | 35.91 | 29.41 | 27.45 | 39.89 | |
PBT Margin (%) | 35.67 | 29.04 | 26.79 | 39.09 | |
Net Profit Margin (%) | 26.98 | 20.88 | 19.49 | 28.64 | |
Return on Networth / Equity (%) | 18.85 | 14.60 | 12.84 | 24.65 | |
Return on Capital Employed (%) | 24.28 | 19.87 | 17.47 | 33.29 | |
Return on Assets (%) | 16.89 | 12.92 | 10.95 | 20.66 | |
Total Debt/Equity (X) | 0.00 | 0.00 | 0.02 | 0.03 | |
Asset Turnover Ratio (%) | 0.68 | 0.66 | 0.59 | 0.90 | |
Liquidity Ratios | |||||
Current Ratio (X) | 5.32 | 5.17 | 4.85 | 4.99 | |
Quick Ratio (X) | 3.88 | 4.06 | 3.64 | 4.06 | |
Inventory Turnover Ratio (X) | 2.28 | 1.90 | 1.80 | 2.41 | |
Dividend Payout Ratio (NP) (%) | 0.00 | 4.05 | 5.37 | 2.89 | |
Dividend Payout Ratio (CP) (%) | 0.00 | 3.57 | 4.74 | 2.71 | |
Earnings Retention Ratio (%) | 0.00 | 95.95 | 94.63 | 97.11 | |
Cash Earnings Retention Ratio (%) | 0.00 | 96.43 | 95.26 | 97.29 | |
Valuation Ratios | |||||
Enterprise Value (Cr.) | 5,824.82 | 2,595.13 | 1,393.89 | 3,760.49 | |
EV/Net Operating Revenue (X) | 8.36 | 4.55 | 3.02 | 7.09 | |
EV/EBITDA (X) | 21.52 | 14.13 | 10.07 | 16.97 | |
MarketCap/Net Operating Revenue (X) | 8.48 | 4.68 | 3.33 | 7.48 | |
Retention Ratios (%) | 0.00 | 95.94 | 94.62 | 97.10 | |
Price/BV (X) | 5.92 | 3.27 | 2.19 | 6.44 | |
Price/Net Operating Revenue | 8.48 | 4.68 | 3.33 | 7.48 | |
Earnings Yield | 0.03 | 0.04 | 0.06 | 0.04 |
22.08.2025
03.06.2025
28.05.2025
Supriya Lifesci Standalone March 2025 Net Sales at Rs 184.11 crore, up 16.39% Y-o-Y
03.04.2025
28.05.2025
Supriya Lifesci Standalone March 2025 Net Sales at Rs 184.11 crore, up 16.39% Y-o-Y
27.01.2025
Supriya Lifesci Standalone December 2024 Net Sales at Rs 185.65 crore, up 32.54% Y-o-Y
29.10.2024
Supriya Lifesci Standalone September 2024 Net Sales at Rs 166.10 crore, up 18.56% Y-o-Y
13.08.2024
Supriya Lifesci Standalone June 2024 Net Sales at Rs 160.63 crore, up 21.67% Y-o-Y